PD

Pagadalu Dharanipathi Chandhana

Active Director Director DIN 11619342
DIN 11619342 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pagadalu Dharanipathi Chandhana

Data last updated:

Pagadalu Dharanipathi Chandhana is a Director at Medrx Health Care Private Limited (since 2026).

DIN 11619342
Primary Designation Director
First Appointment 19 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medrx Health Care Private Limited U26600KA2026PTC218021
Director19 Mar 20262026Active

Board colleagues of Pagadalu Dharanipathi Chandhana

Directorship timeline

Open interactive timeline →
Medrx Health Care Private Limited
Premium access

Shareholding and investment profile for Pagadalu Dharanipathi Chandhana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pagadalu Dharanipathi Chandhana

Pagadalu Dharanipathi Chandhana currently holds 1 directorship: Medrx Health Care Private Limited (Director, since 19 Mar 2026).

Pagadalu Dharanipathi Chandhana was first appointed on 19 Mar 2026 as Director at Medrx Health Care Private Limited.

The current boards of Pagadalu Dharanipathi Chandhana's companies include Nirmala Manjunath Skanda Prasad (Medrx Health Care Private Limited), Somahalli Vijayakumar Shreemanth Kumar (Medrx Health Care Private Limited), Srinivas Mohan (Medrx Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available